Scinai Immunotherapeutics Statistics
Total Valuation
SCNI has a market cap or net worth of $3.83 million. The enterprise value is $5.19 million.
Important Dates
The last earnings date was Monday, November 24, 2025, before market open.
| Earnings Date | Nov 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SCNI has 3.19 million shares outstanding. The number of shares has increased by 157.30% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 3.19M |
| Shares Change (YoY) | +157.30% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 11.41% |
| Owned by Institutions (%) | 5.16% |
| Float | 2.78M |
Valuation Ratios
The trailing PE ratio is 4.55.
| PE Ratio | 4.55 |
| Forward PE | n/a |
| PS Ratio | 1.38 |
| Forward PS | n/a |
| PB Ratio | 0.81 |
| P/TBV Ratio | 1.71 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 14.96 |
| EV / Sales | 4.53 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.71, with a Debt / Equity ratio of 0.30.
| Current Ratio | 0.71 |
| Quick Ratio | 0.53 |
| Debt / Equity | 0.30 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.67 |
Financial Efficiency
Return on equity (ROE) is 1,791.99% and return on invested capital (ROIC) is -44.45%.
| Return on Equity (ROE) | 1,791.99% |
| Return on Assets (ROA) | -39.55% |
| Return on Invested Capital (ROIC) | -44.45% |
| Return on Capital Employed (ROCE) | -86.89% |
| Revenue Per Employee | $37,000 |
| Profits Per Employee | $11,194 |
| Employee Count | 31 |
| Asset Turnover | 0.09 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.02% in the last 52 weeks. The beta is 1.67, so SCNI's price volatility has been higher than the market average.
| Beta (5Y) | 1.67 |
| 52-Week Price Change | -63.02% |
| 50-Day Moving Average | 1.23 |
| 200-Day Moving Average | 2.08 |
| Relative Strength Index (RSI) | 56.61 |
| Average Volume (20 Days) | 42,179 |
Short Selling Information
| Short Interest | 13,941 |
| Short Previous Month | 53,496 |
| Short % of Shares Out | 0.44% |
| Short % of Float | 0.50% |
| Short Ratio (days to cover) | 0.19 |
Income Statement
In the last 12 months, SCNI had revenue of $1.15 million and earned $347,000 in profits. Earnings per share was $0.26.
| Revenue | 1.15M |
| Gross Profit | -1.69M |
| Operating Income | -8.45M |
| Pretax Income | 5.14M |
| Net Income | 347,000 |
| EBITDA | -6.75M |
| EBIT | -8.45M |
| Earnings Per Share (EPS) | $0.26 |
Full Income StatementBalance Sheet
The company has $989,000 in cash and $2.36 million in debt, giving a net cash position of -$1.37 million or -$0.43 per share.
| Cash & Cash Equivalents | 989,000 |
| Total Debt | 2.36M |
| Net Cash | -1.37M |
| Net Cash Per Share | -$0.43 |
| Equity (Book Value) | 7.86M |
| Book Value Per Share | 1.47 |
| Working Capital | -614,000 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$5.69 million and capital expenditures -$16,000, giving a free cash flow of -$5.71 million.
| Operating Cash Flow | -5.69M |
| Capital Expenditures | -16,000 |
| Free Cash Flow | -5.71M |
| FCF Per Share | -$1.79 |
Full Cash Flow StatementMargins
Gross margin is -146.99%, with operating and profit margins of -736.36% and 448.39%.
| Gross Margin | -146.99% |
| Operating Margin | -736.36% |
| Pretax Margin | 448.39% |
| Profit Margin | 448.39% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |